AGAPE ATP CORPORATION Increase (Decrease) in Accounts Payable
AGAPE ATP CORPORATION (ATPC) reported Increase (Decrease) in Accounts Payable of -$2.80 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2020-11-16
- AGAPE ATP CORPORATION increase (decrease) in accounts payable for the quarter ending 2020-09-30 was -$2.00.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable for the quarter ending 2020-06-30 was $1.00, a 100.00% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable for the quarter ending 2020-03-31 was -$2.80K, a 311.87% decline year-over-year.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable for the quarter ending 2019-12-31 was $37.92K.
- AGAPE ATP CORPORATION increase (decrease) in accounts payable for fiscal 2019 was $35.15K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$1.00 derived: sum of 2 quarters · filed 2020-11-16 | -$2.80K 10-Q · filed 2020-11-16 | $35.12K derived: sum of 4 quarters · filed 2020-11-16 |
| 2020-06-30 | $1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$2.80K 10-Q · filed 2020-08-13 | $35.12K derived: sum of 3 quarters · filed 2020-08-13 | -$24.00 derived: sum of 4 quarters · filed 2020-08-13 |
| 2020-03-31 | -$2.80K 10-Q · filed 2020-05-14 | $35.12K derived: sum of 2 quarters · filed 2020-05-14 | -$25.00 derived: sum of 3 quarters · filed 2020-05-14 | $33.80K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-12-31 | $37.92K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | $2.78K 10-K · filed 2020-03-27 | $36.60K derived: sum of 3 quarters · filed 2020-03-27 | $37.92K derived: sum of 4 quarters · filed 2020-05-14 |
| 2019-09-30 | -$35.15K 10-Q · filed 2019-11-12 | -$1.32K derived: sum of 2 quarters · filed 2019-12-02 | $0.00 derived: sum of 3 quarters · filed 2020-05-14 | |
| 2019-06-30 | $33.82K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-12-02 | $35.15K derived: sum of 2 quarters · filed 2020-05-14 | $35.15K 10-K/A · filed 2019-12-02 | |
| 2019-03-31 | $1.32K 10-Q · filed 2020-05-14 | $1.32K 10-Q · filed 2019-05-13 | ||
| 2018-09-30 | $47.64K 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | -$255.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-15 | $131.16K 10-Q · filed 2019-02-15 | ||
| 2017-09-30 | $387.05K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |